Guided Therapeutics (GTHP) Receives Grant to Assist in Commercialization of Cervical Cancer Detection Technology
Guided Therapeutics Inc. is developing a rapid and painless testing platform based on its patented biophotonics technology for the early detection of disease. The National Cancer Institute recently awarded the company $517,000 to fund the final year of a $2.5 million, three-year grant. The grant provides the company with the necessary resources to help commercialize and bring to market the LuViva(TM) Advanced Cervical Scan and Cervical Guide single-patient-use disposable. LuViva is a non-invasive device that provides immediate detection of cervical disease by scanning the cervix with light, instantly detecting and identifying cancer and pre-cancer. The technology is a stark contrast…